Evaluating the therapeutic efficacy of nano-drugs targeting epidermal growth factor receptor

Chem Commun (Camb). 2022 Feb 22;58(16):2726-2729. doi: 10.1039/d1cc06754k.

Abstract

Epidermal growth factor receptor (EGFR) targeted nano-drugs facilitate effective diagnosis and treatment of cancer. Herein, the therapeutic efficacy of nano-drugs targeting EGFR was evaluated from the perspective of cell entry efficiency and induced cell mechanical properties using force tracing and nano-indentation techniques at the single particle/cell level in real time.

MeSH terms

  • A549 Cells
  • ErbB Receptors / antagonists & inhibitors
  • ErbB Receptors / metabolism
  • Humans
  • Nanoparticles / chemistry*
  • Polyamines / chemistry
  • Polyamines / pharmacology*
  • Protein Kinase Inhibitors / chemistry
  • Protein Kinase Inhibitors / pharmacology*

Substances

  • Poly(amidoamine)
  • Polyamines
  • Protein Kinase Inhibitors
  • EGFR protein, human
  • ErbB Receptors